JP2012522994A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522994A5
JP2012522994A5 JP2012503717A JP2012503717A JP2012522994A5 JP 2012522994 A5 JP2012522994 A5 JP 2012522994A5 JP 2012503717 A JP2012503717 A JP 2012503717A JP 2012503717 A JP2012503717 A JP 2012503717A JP 2012522994 A5 JP2012522994 A5 JP 2012522994A5
Authority
JP
Japan
Prior art keywords
expression
positive control
biomarkers
mmp
regulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012503717A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012522994A (ja
JP5643288B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/029674 external-priority patent/WO2010115034A2/en
Publication of JP2012522994A publication Critical patent/JP2012522994A/ja
Publication of JP2012522994A5 publication Critical patent/JP2012522994A5/ja
Application granted granted Critical
Publication of JP5643288B2 publication Critical patent/JP5643288B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012503717A 2009-04-01 2010-04-01 軟組織疾患の診断のための、および口腔ケア介入のための療法的標的としてのタンパク質バイオマーカー Expired - Fee Related JP5643288B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01
US61/165,674 2009-04-01
PCT/US2010/029674 WO2010115034A2 (en) 2009-04-01 2010-04-01 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Publications (3)

Publication Number Publication Date
JP2012522994A JP2012522994A (ja) 2012-09-27
JP2012522994A5 true JP2012522994A5 (enExample) 2013-05-16
JP5643288B2 JP5643288B2 (ja) 2014-12-17

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012503717A Expired - Fee Related JP5643288B2 (ja) 2009-04-01 2010-04-01 軟組織疾患の診断のための、および口腔ケア介入のための療法的標的としてのタンパク質バイオマーカー

Country Status (15)

Country Link
US (1) US8753820B2 (enExample)
EP (1) EP2414837B1 (enExample)
JP (1) JP5643288B2 (enExample)
CN (1) CN102549432B (enExample)
AR (1) AR076041A1 (enExample)
BR (1) BRPI1013184A2 (enExample)
CA (1) CA2753718C (enExample)
CO (1) CO6430490A2 (enExample)
MX (1) MX2011008439A (enExample)
MY (1) MY179250A (enExample)
RU (1) RU2523383C2 (enExample)
SG (1) SG173461A1 (enExample)
TW (1) TWI481870B (enExample)
WO (1) WO2010115034A2 (enExample)
ZA (1) ZA201106056B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI405565B (zh) * 2009-04-01 2013-08-21 Colgate Palmolive Co 口腔用組成物之抗-骨質流失及抗-牙周附連喪失之功效
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
WO2018129043A1 (en) * 2017-01-03 2018-07-12 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
JP7486316B2 (ja) 2017-05-24 2024-05-17 コーニンクレッカ フィリップス エヌ ヴェ 唾液のil-1ベータ及びmmp-9に基づく軽度の又は進行した歯周炎の診断
EP3631458A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of periodontitis based on salivary hgf and mmp-8
WO2018215596A1 (en) * 2017-05-24 2018-11-29 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
WO2019084351A1 (en) 2017-10-27 2019-05-02 The Regents Of The University Of California SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
EP0935454B1 (de) 1996-06-12 2001-08-22 Cognis Deutschland GmbH Kosmetische und/oder pharmazeutische zubereitungen
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
WO2001048481A1 (en) 1999-12-03 2001-07-05 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
WO2001078652A2 (en) 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
TW200902047A (en) 2003-02-14 2009-01-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
WO2005039504A2 (en) 2003-10-24 2005-05-06 Eisai Co., Ltd. Compounds and methods for treating toll-like receptor 2-related diseases and conditions
US20070212686A1 (en) 2003-12-03 2007-09-13 Whitehead Institute For Biomedical Research Use Of T-Cadherin As A Target
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
WO2006068133A1 (ja) * 2004-12-21 2006-06-29 National University Corporation NARA Institute of Science and Technology Nfat2発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
RU2431845C2 (ru) * 2006-01-10 2011-10-20 Колгейт-Палмолив Компани Способы модулирования рецепторов клеточных поверхностей для предотвращения или снижения воспаления
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails

Similar Documents

Publication Publication Date Title
JP2012522994A5 (enExample)
Meganathan et al. Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells
Hartley et al. Long-lasting changes in DNA methylation following short-term hypoxic exposure in primary hippocampal neuronal cultures
EA202190075A3 (ru) Анализ транскриптома материнской плазмы с применением массивного параллельного секвенирования рнк
JP2013518244A5 (enExample)
MX2015015532A (es) Metodo y sistema de identificacion de biomarcadores.
RU2011144032A (ru) Протеиновые биомаркеры для диагностики заболевания мягких тканей и в качестве терапевтических мишеней для вмешательства в гигиену полости рта
GB201300533D0 (en) Methods of monitoring conditions by sequence analysis
JP2014223088A5 (enExample)
RU2012106742A (ru) Способ диагностики и/или прогнозирования острого повреждения почек
RU2011111875A (ru) Способ прогнозирования развития осложнений у больных внебольничной пневмонией
Philpot et al. Predicting the likelihood of bronchopulmonary dysplasia in premature neonates
JP2012524884A5 (enExample)
EA201500939A1 (ru) Определение геномов плодов при многоплодных беременностях
WO2005108619A3 (en) Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
WO2010097706A3 (en) Methods and compositions for evaluating chronic immune diseases
RU2012144558A (ru) Способ лабораторной диагностики септической энцефалопатии у новорожденных с перинатальным гипоксическим поражением цнс
Tella et al. Association between Maternal FUT2 204A> G (rs492602) Genetic Polymorphism and Congenital Heart Disease in the Indian Population: A Study in Maternal-fetal Dyads
JP2013525820A5 (enExample)
RU2009109909A (ru) Способ прогнозирования исхода тяжелой острой черепно-мозговой травмы
Nakano et al. Lipocalin-2: A novel biomarker for lung hypoplasia in congenital diaphragmatic hernia fetus
WO2014186361A3 (en) Pharmacogenomic biomarkers for b cell malignancies and methods of use thereof
Aita Genetics in TNF-TNFR pathway: a complex network causing spondyloarthritis and conditioning response to therapy
Seumois et al. A110 LATE BREAKING ABSTRACTS IN DISEASE SUSCEPTIBILITY AND PATHOGENESIS: Epigenomic Analysis Of Primary Human T Cells Reveals Novel Enhancers Associated With Th2 Memory Differentiation And Asthma Susceptibility
Trotta The inflammasome and its components: new markers for advanced diagnostic in rheumatology.